Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort studyFrancesco Passamonti, Celestino Ferrandina, Michèle Cavo et al.|The Lancet Haematology|2020Cited by 553
Prognostic significance of <i>FCGR2B</i> expression for the response of DLBCL patients to rituximab or obinutuzumab treatmentMałgorzata Nowicka, Mark S. Cragg, Laura K. Hilton et al.|Blood Advances|2021Cited by 18